Tuesday, June 28, 2016 2:49:24 PM
QURE
Recent QURE News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:35:21 AM
- uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease • GlobeNewswire Inc. • 09/23/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:48:04 AM
- uniQure Announces Dosing of First Patient in Phase I/IIa Clinical Trial of AMT-191 for the Treatment of Fabry Disease • GlobeNewswire Inc. • 08/15/2024 11:05:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/01/2024 12:54:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:51:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 11:43:22 AM
- uniQure Announces Second Quarter 2024 Financial Results and Provides Company Update • GlobeNewswire Inc. • 08/01/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:10:32 AM
- uniQure Announces Closing of Sale of Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/23/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 11:13:10 AM
- uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for Huntington’s Disease • GlobeNewswire Inc. • 07/09/2024 11:05:00 AM
- uniQure Announces Sale of Commercial Manufacturing Facility to Genezen • GlobeNewswire Inc. • 07/01/2024 11:05:00 AM
- Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA • PR Newswire (US) • 07/01/2024 11:05:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:53:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 12:49:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 10:00:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:46:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:40:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:24:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:19:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 10:42:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:18:51 AM
- uniQure Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Investigational Gene Therapy AMT-130 in Huntington’s Disease • GlobeNewswire Inc. • 06/03/2024 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 12:03:45 PM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM